Back to results
Active, not recruitingEARLY_Phase 1

Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials

NCT06489015

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Luoyang Third People's Hospital

Luoyang, Henan, China

+4 additional locations

View on ClinicalTrials.gov